{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:47:31Z","timestamp":1769093251656,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-017-1878-5","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T08:50:57Z","timestamp":1513155057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment"],"prefix":"10.1186","volume":"18","author":[{"given":"Wen-Ling","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Sheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lih-Huei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-6208","authenticated-orcid":false,"given":"Tung-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"issue":"6","key":"1878_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjopharm.2009.12.004","volume":"7","author":"BJ Gates","year":"2009","unstructured":"Gates BJ, et al. Review of osteoporosis pharmacotherapy for geriatric patients. Am J Geriatr Pharmacother. 2009;7(6):293\u2013323.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"1878_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008;148(3):197\u2013213.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1878_CR3","first-page":"349","volume":"89","author":"SK Goh","year":"2007","unstructured":"Goh SK, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89(3):349\u201353.","journal-title":"J Bone Joint Surg Br"},{"issue":"2","key":"1878_CR4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"EB Kwek","year":"2008","unstructured":"Kwek EB, et al. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39(2):224\u201331.","journal-title":"Injury"},{"issue":"6","key":"1878_CR5","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2106\/00004623-200806000-00028","volume":"90","author":"L Gehrig","year":"2008","unstructured":"Gehrig L, Lane J, O'Connor MI. Osteoporosis: management and treatment strategies for orthopaedic surgeons. J Bone Joint Surg Am. 2008;90(6):1362\u201374.","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"1878_CR6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","volume":"28","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res. 2013;28(8):1729\u201337.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1878_CR7","doi-asserted-by":"crossref","first-page":"e8 1","DOI":"10.2106\/JBJS.L.00568","volume":"95","author":"A Unnanuntana","year":"2013","unstructured":"Unnanuntana A, et al. Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection. J Bone Joint Surg Am. 2013;95(2):e8 1\u201313.","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"1878_CR8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","volume":"20","author":"BA Lenart","year":"2009","unstructured":"Lenart BA, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporosis International. 2009;20(8):1353\u201362.","journal-title":"Osteoporosis International"},{"issue":"5","key":"1878_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","volume":"22","author":"AS Neviaser","year":"2008","unstructured":"Neviaser AS, et al. Low-energy femoral shaft fractures associated with alendronate use. Journal of Orthopaedic Trauma. 2008;22(5):346\u201350.","journal-title":"Journal of Orthopaedic Trauma"},{"issue":"8","key":"1878_CR10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"LY Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LY, et al. Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women. Jama-Journal of the American Medical Association. 2011;305(8):783\u20139.","journal-title":"Jama-Journal of the American Medical Association"},{"issue":"2","key":"1878_CR11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ocl.2013.01.001","volume":"44","author":"A Saleh","year":"2013","unstructured":"Saleh A, et al. Bisphosphonate therapy and atypical fractures. Orthop Clin North Am. 2013;44(2):137\u201351.","journal-title":"Orthop Clin North Am"},{"issue":"21","key":"1878_CR12","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2174\/1381612043383737","volume":"10","author":"N Miyakoshi","year":"2004","unstructured":"Miyakoshi N. Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis. Curr Pharm Des. 2004;10(21):2615\u201327.","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"1878_CR13","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S0020-1383(13)70013-5","volume":"44","author":"L Pietrogrande","year":"2013","unstructured":"Pietrogrande L, Raimondo E. Teriparatide in the treatment of non-unions: scientific and clinical evidences. Injury. 2013;44(Suppl 1):S54\u20137.","journal-title":"Injury"},{"key":"1878_CR14","volume-title":"Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures","author":"F Fukuda","year":"2014","unstructured":"Fukuda, F., N. Kurinomaru, and A. Hijioka, Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures. Biol Ther, 2014."},{"issue":"9","key":"1878_CR15","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1210\/jc.2011-0593","volume":"96","author":"NNC Carvalho","year":"2011","unstructured":"Carvalho NNC, et al. Atypical Femoral Fractures during Prolonged Use of Bisphosphonates: Short-Term Responses to Strontium Ranelate and Teriparatide. Journal of Clinical Endocrinology & Metabolism. 2011;96(9):2675\u201380.","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"12","key":"1878_CR16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/gme.0b013e318260143d","volume":"19","author":"HT Huang","year":"2012","unstructured":"Huang HT, et al. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report. Menopause. 2012;19(12):1360\u20133.","journal-title":"Menopause"},{"issue":"6","key":"1878_CR17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jc.2010-2520","volume":"96","author":"SJ Gomberg","year":"2011","unstructured":"Gomberg SJ, et al. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab. 2011;96(6):1627\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1878_CR18","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1210\/jc.2011-0593","volume":"96","author":"NN Carvalho","year":"2011","unstructured":"Carvalho NN, et al. Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide. J Clin Endocrinol Metab. 2011;96(9):2675\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"1878_CR19","first-page":"213614","volume":"2015","author":"H Tsuchie","year":"2015","unstructured":"Tsuchie H, et al. Combined Effect of a Locking Plate and Teriparatide for Incomplete Atypical Femoral Fracture: Two Case Reports of Curved Femurs. Case Rep Orthop. 2015;2015:213614.","journal-title":"Case Rep Orthop"},{"issue":"2","key":"1878_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5152\/eurjrheum.2015.0010","volume":"3","author":"SR Mastaglia","year":"2016","unstructured":"Mastaglia SR, Aguilar G, Oliveri B. Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use. Eur J Rheumatol. 2016;3(2):87\u201390.","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"1878_CR21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bone.2012.10.006","volume":"52","author":"CY Chiang","year":"2013","unstructured":"Chiang CY, et al. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone. 2013;52(1):360\u20135.","journal-title":"Bone"},{"issue":"2","key":"1878_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11420-012-9275-y","volume":"8","author":"A Saleh","year":"2012","unstructured":"Saleh A, et al. Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J. 2012;8(2):103\u201310.","journal-title":"HSS J"},{"issue":"5","key":"1878_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5435\/JAAOS-20-05-273","volume":"20","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, et al. Assessment of compromised fracture healing. J Am Acad Orthop Surg. 2012;20(5):273\u201382.","journal-title":"J Am Acad Orthop Surg"},{"issue":"4","key":"1878_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2106\/00004623-196951040-00012","volume":"51","author":"WH Harris","year":"1969","unstructured":"Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51(4):737\u201355.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"1878_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1302\/0301-620X.94B3.27999","volume":"94","author":"RN Thompson","year":"2012","unstructured":"Thompson RN, et al. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Joint Surg Br. 2012;94(3):385\u201390.","journal-title":"J Bone Joint Surg Br"},{"issue":"12","key":"1878_CR26","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","volume":"172","author":"RP Meier","year":"2012","unstructured":"Meier RP, et al. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med. 2012;172(12):930\u20136.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1878_CR27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar4013","volume":"14","author":"MC van der Meulen","year":"2012","unstructured":"van der Meulen MC, Boskey AL. Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality. Arthritis Res Ther. 2012;14(4):220.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1878_CR28","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","volume":"22","author":"J Compston","year":"2011","unstructured":"Compston J. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int. 2011;22(12):2951\u201361.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1878_CR29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.070609","volume":"22","author":"RD Chapurlat","year":"2007","unstructured":"Chapurlat RD, et al. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study. Journal of Bone and Mineral Research. 2007;22(10):1502\u20139.","journal-title":"Journal of Bone and Mineral Research"},{"key":"1878_CR30","unstructured":"Schilcher J. Bisphosphonate Use and Atypical Fractures of the Femoral Shaft (vol 364, pg 1728, 2011). New England Journal of Medicine. 2012;367(6):582\u20132."},{"issue":"11","key":"1878_CR31","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25(11):2267\u201394.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"1878_CR32","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","volume":"93","author":"M Visekruna","year":"2008","unstructured":"Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008;93(8):2948\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1878_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29(1):1\u201323.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1878_CR34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.injury.2008.09.010","volume":"40","author":"W Ekstrom","year":"2009","unstructured":"Ekstrom W, et al. Quality of life after a subtrochanteric fracture: a prospective cohort study on 87 elderly patients. Injury. 2009;40(4):371\u20136.","journal-title":"Injury"},{"issue":"5","key":"1878_CR35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1302\/0301-620X.96B5.32887","volume":"96-B","author":"BJ Teo","year":"2014","unstructured":"Teo BJ, et al. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Joint J. 2014;96-B(5):658\u201364.","journal-title":"Bone Joint J"},{"issue":"7","key":"1878_CR36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/BOT.0000000000000851","volume":"31","author":"AJ Lovy","year":"2017","unstructured":"Lovy AJ, et al. Intramedullary Nail Fixation of Atypical Femur Fractures With Bone Marrow Aspirate Concentrate Leads to Faster Union: A Case-Control Study. J Orthop Trauma. 2017;31(7):358\u201362.","journal-title":"J Orthop Trauma"},{"issue":"1","key":"1878_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00198-003-1490-4","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38\u201342.","journal-title":"Osteoporos Int"},{"issue":"14","key":"1878_CR38","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA, et al. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302(14):1573\u20139.","journal-title":"JAMA"},{"issue":"7","key":"1878_CR39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s001980070075","volume":"11","author":"JA Cauley","year":"2000","unstructured":"Cauley JA, et al. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11(7):556\u201361.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1878_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2106\/JBJS.K.01181","volume":"95","author":"BJ Edwards","year":"2013","unstructured":"Edwards BJ, et al. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am. 2013;95(4):297\u2013307.","journal-title":"J Bone Joint Surg Am"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-017-1878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T08:51:18Z","timestamp":1513155078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-017-1878-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1186\/s12891-017-1878-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"527"}}